BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo GS, Yu JI, Cho S, Jung SH, Han Y, Park S, Oh Y, Lee B, Park HC, Lim DH, Choi MS, Won H. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma. Radiother Oncol 2020;146:187-93. [PMID: 32179362 DOI: 10.1016/j.radonc.2020.02.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Byun HK, Han MC, Yang K, Kim JS, Yoo GS, Koom WS, Kim YB. Physical and Biological Characteristics of Particle Therapy for Oncologists. Cancer Res Treat 2021;53:611-20. [PMID: 34139805 DOI: 10.4143/crt.2021.066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim N, Myoung Noh J, Lee W, Park B, Park H, Young Park J, Pyo H. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy. Radiother Oncol 2021;156:166-73. [PMID: 33359267 DOI: 10.1016/j.radonc.2020.12.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Noh JM, Yoo H, Lee W, Park HY, Shin SH, Pyo H. Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis. Cancers 2022;14:1445. [DOI: 10.3390/cancers14061445] [Reference Citation Analysis]
4 Lee CH, Chen AH, Hung SP, Hsieh CE, Tseng JH, Chen PJ, Cheng JY, Chang JT, Chan KM, Lin SM, Lin CC, Chen WT, Chen WY, Huang BS. Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion. Cancers (Basel) 2022;14:1616. [PMID: 35406392 DOI: 10.3390/cancers14071616] [Reference Citation Analysis]
5 Chang S, Liu G, Zhao L, Zheng W, Yan D, Chen P, Li X, Yang K, Deraniyagala R, Stevens C, Grills I, Chinnaiyan P, Li X, Ding X. Redefine the Role of Spot-Scanning Proton Beam Therapy for the Single Brain Metastasis Stereotactic Radiosurgery. Front Oncol 2022;12:804036. [DOI: 10.3389/fonc.2022.804036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yu JI, Kang W, Yoo GS, Goh MJ, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Hong JY, Lim HY, Park B, Park HC. Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis. Front Oncol 2022;12:888755. [PMID: 35646674 DOI: 10.3389/fonc.2022.888755] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Takemasa K, Kato T, Narita Y, Kato M, Yamazaki Y, Ouchi H, Oyama S, Yamaguchi H, Wada H, Murakami M. The impact of different setup methods on the dose distribution in proton therapy for hepatocellular carcinoma. J Appl Clin Med Phys 2021;22:63-71. [PMID: 33595910 DOI: 10.1002/acm2.13178] [Reference Citation Analysis]
8 Siregar H, Bäumer C, Blanck O, Chan M, Engwall E, Plaude S, Spaan B, Timmermann B, Wulff J. Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma. Zeitschrift für Medizinische Physik 2020. [DOI: 10.1016/j.zemedi.2020.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Yoo GS, Yu JI, Park HC, Hyun D, Jeong WK, Lim HY, Choi MS, Ha SY. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter? Cancers (Basel) 2020;12:E2395. [PMID: 32847035 DOI: 10.3390/cancers12092395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yoo GS, Yu JI, Park HC. Current role of proton beam therapy in patients with hepatocellular carcinoma. Int J Gastrointest Interv 2021;10:175-82. [DOI: 10.18528/ijgii210043] [Reference Citation Analysis]
11 Kobeissi JM, Hilal L, Simone CB 2nd, Lin H, Crane CH, Hajj C. Proton Therapy in the Management of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:2900. [PMID: 35740567 DOI: 10.3390/cancers14122900] [Reference Citation Analysis]
12 Lee B, Cho S, Park HC, Kang SW, Kim JS, Chung JB. Assessment of dose perturbations for metal stent in photon and proton radiotherapy plans for hepatocellular carcinoma. Radiat Oncol 2022;17:125. [PMID: 35842636 DOI: 10.1186/s13014-022-02100-8] [Reference Citation Analysis]
13 Kreinbrink PJ, Lewis LM, Redmond KP, Takiar V. Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence. Curr Treat Options Oncol 2022;23:295-310. [PMID: 35226310 DOI: 10.1007/s11864-021-00936-y] [Reference Citation Analysis]
14 Kim N, Noh JM, Lee W, Park B, Pyo H. Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis. Cancers (Basel) 2021;13:3497. [PMID: 34298711 DOI: 10.3390/cancers13143497] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Bhangoo RS, Mullikin TC, Ashman JB, Cheng TW, Golafshar MA, DeWees TA, Johnson JE, Shiraishi S, Liu W, Hu Y, Merrell KW, Haddock MG, Krishnan S, Rule WG, Sio TT, Hallemeier CL. Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience. Adv Radiat Oncol 2021;6:100675. [PMID: 34409199 DOI: 10.1016/j.adro.2021.100675] [Reference Citation Analysis]
16 Kubeš J, Haas A, Vondráček V, Andrlík M, Navrátil M, Sláviková S, Vítek P, Dědečková K, Prausová J, Ondrová B, Vinakurau Š, Grebenyuk A, Doležal T, Velacková B, Rosina J. Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes. Int J Radiat Oncol Biol Phys 2021;110:1090-7. [PMID: 33587990 DOI: 10.1016/j.ijrobp.2021.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]